Sign up for periodic reports and bulletins
FREE access; FREE of commercials; FREE to use
Posted July 24, 2013: by Bill Sardi
The Saisei Mirai Clinics in Kobe, Japan have taken their “cancer cure” online and graphically describe how it works, including published studies for the more scientific investigator. A key part of the therapy is injection of Gc-macrophage activating factor (Gc-MAF) which is gleaned from blood samples of healthy adults. Gc-MAF instructs white blood cells called macrophages to destroy cancerous cells as well as other foreign invaders like viruses.
The Saisei Mirai Clinics report they have successfully treated 345 consecutive patients with terminal metastatic (spreading) cancer. Some cases are reported at the website. They include the case of a 62-year old woman who was diagnosed with uterine cancer with spreading to the lymph nodes in 2011 and had undergone two prior chemotherapy sessions. After a battery of treatments to boost her own immune system, she achieved complete remission from cancer in 2013 (no tumor visible on CAT scan and normal tumor markers).
The second case is that of a 71-year old male with cancer of his thymus gland with spreading to the lung. He received 48 doses of Gc-MAF and weekly intravenous vitamin C. The patient is reportedly doing well.
A third case is that of a 74-year old man with prostate cancer that had spread to the bone. He received 48 weekly doses of Gc-MAF, 39 rounds of intravenous vitamin C and heat therapy. The patient is reported to have had “a complete response.” All evidence of tumors have vanished.
A fourth case is that of a 72-year old female with colon cancer that had spread to the liver, ovaries and peritoneum. After surgical removal of tumors, she received 48-doses of Gc-MAF and 66 rounds of intravenous vitamin C along with radiation treatment. Scans reveal no tumors.
Gc-MAF is also available for shipping worldwide directly from Japan. It comes to about $83/dose. About 24 weekly doses were utilized in a recent published report in the Journal of Anticancer Research.
To learn more, visit their website.
You must be logged in to post a comment.